| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human KIR2DS4/CD158i Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie? Blue Staining. MW (observed): 70-85 kDa, reducing conditions. MW (theoretical): 51.2 kDa (monomer). The Recombinant Human KIR2DS4/CD158i Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human KIR2DS4/CD158i Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD158 antigen-like family member I, CD158I, CD158i antigen, cl-39, killer cell immunoglobulin-like receptor 2DS4, killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail4,nkat8, killer inhibitory receptor 4-1-2, KIR antigen 2DS4, KKA3KIR1D, MGC120019, MGC125315, MGC125317, MHC class I NK cell receptor, natural killer cell inhibitory receptor, Natural killer-associated transcript 8, NKAT-8, NKAT8KIR412, P58 natural killer cell receptor clones CL-39/CL-17, p58 NK receptor CL-39/CL-17 |
|---|
| Gene, Accession, CAS # | KIR2DS4, Gene ID: 3809, Accession: P43632 |
|---|
| Catalog # | 1847-KR-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human KIR2DS4/CD158i Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 28723950 |
|---|
| 產(chǎn)品資料 |
|
|